Antares Pharma, Inc. (NASDAQ: ATRS) today announced the publication of three abstracts at this year’s European League against Rheumatism (EULAR) Annual Congress being held in Paris, France on June 11 through June 14, 2014.
In partnership with clinical researchers in the United States and Europe, Antares Pharma, the maker of OTREXUP™ (methotrexate) for subcutaneous injection, supports original research intended to better understand the clinical role of subcutaneous methotrexate in the treatment of rheumatoid arthritis.
Help employers find you! Check out all the jobs and post your resume.
